chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sweating for 1hs and 2hs in my sleep, like from my waist to my neck; Felt very tired, fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck) and FATIGUE (Felt very tired, fatigue) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient already had COVID-19 a couple of months ago, finished with it on December 7th or 8th.) in December 2020. Concurrent medical conditions included Hypertension.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced FATIGUE (Felt very tired, fatigue). On 08-Mar-2021, the patient experienced HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck). On 06-Mar-2021, FATIGUE (Felt very tired, fatigue) had resolved. At the time of the report, HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 antibody test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Tdap given 4/12 and next day. Patient with F to 102.6, HA and nausea. Sx care at home recommended for virus vs vaccine rexn.
It was reported that a 20 year old female pt received a Menomune A/C/Y/W-135 vaccination on 11/30/99. Reportedly, the pt was running a fever initially after the vaccination. Approx. 1 week, post vax, on 12/6/99, the pt developed a hard-reddened area of her left upper arm about the size of an orange. Reportedly, the pt recovered from this experience.
Runny nose, HA  (from "my eyeballs to the top of my head.") for 5 days - developed into a sore throat and a cough for 3 more days - has cleared up now.
I developed fatigue and muscle soreness.  It happened quickly, it didn't start out slowly and build up, it lasted for about 2 hours then completely subsided.  There was no other known cause.  When researching side effects I could not find any information that described this scenario.  Thank You
hair loss; extreme dizziness; tingling and swollen lips; tingling and swollen lips; decreased left ear hearing; joint pain/extreme joint pain; brain fog; fatigue; This is a spontaneous report from a non-contactable healthcare professional (patient). A non-pregnant 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in right arm on 13Jan2021 (Lot Number: ek4176, unknown expiration; at the age of 46 years old) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included colecalciferol (VITAMIN D); biotin; and unspecified multivitamin.  The patient previously took Percocet, amoxicillin, and doxycycline, and has known allergies to it. On 13Jan2021, few hours after the vaccination, the patient experienced extreme dizziness, tingling and swollen lips, decreased left ear hearing, joint pain, brain fog, and fatigue. Now (on 10Aug2021), the patient experienced hair loss and extreme joint pain, and dizziness on and off 8 months later. No COVID prior vaccination and has not been tested for COVID post vaccination. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the events. The patient had not yet recovered from the events.   No follow-up attempts are possible; information about batch number was already obtained.; Sender's Comments: Based on the available information and the strong drug event temporal association, a possible contributory role of suspect product BNT162B2 to development of events dizziness, paraesthesia oral, lip swelling, hypoacusis, Arthralgia, feeling abnormal, fatigue and alopecia cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Almost fainted after shot, then had bad stomach cramps. Menstrual cycle restarted that night and cessation of future cycles occurred.
Approx 24 H post-immunization patient showered at home. When bathing complete, patient noted rash on all body surfaces. No difficulty breathing. Patient called MD and reported in person to pharmacy.
He got a fever from the booster shot which lasted 5 to 6 days and it reached 102.5F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (He got a fever from the booster shot which lasted 5 to 6 days and it reached 102.5F) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (He got a fever from the booster shot which lasted 5 to 6 days and it reached 102.5F). At the time of the report, PYREXIA (He got a fever from the booster shot which lasted 5 to 6 days and it reached 102.5F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102.5 (High) 102.5F.         No concomitant medications were reported. No treatment mediations were reported. Patient mentioned he got a fever from the booster shot which lasted 5 to 6 days and it reached 102.5F.   Reporter did not allow further contact
Shingles; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported that a male patient of an unspecified age (reported as 58) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced shingles 4 days before the 2nd dose. The outcome of the event was unknown.    No follow-up attempts are possible; information about lot/batch number cannot been obtained
This case was reported by a pharmacist via call center representative and described the occurrence of shivering in a adult male patient who received SHINGRIX (batch number YS53Y, expiry date unknown). On an unknown date, the patient received SHINGRIX (subcutaneous). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shivering, headache and intramuscular formulation administered by other route. On an unknown date, the outcome of the shivering, headache and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the shivering and headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient inadvertently received SHINGRIX subcutaneously instead of intramuscularly, which led to intramuscular formulation administered by other route. The reporter was unable to provide the expiration date of the SHINGRIX because the system defaulted to 1 year from administration. On 3rd May 2018, the reporter was contacted via phone for the medical information. It was an accidental medication error with adverse event. The pharmacist did not have any additional details.
Developed localized reaction at injection site 55 cm in diameter. Red, hot and tender to touch.
Pt received DTaP, IPV-combined & PCV 13 in left leg, MMR-arm & VZV in arm approx: 130. At 10:00 pm woke screaming in pain. Refused to move her legs - per mom both knees looked swollen but (R) looked worse than (L). When seen in office pt still had slight limp.
Pain at deltoid site of injection site radiates down to fingers. Localized numbness about 2 cm circumference. Ongoing for 9 days.
Contracted COVID infection - sore throat, achiness, fatigue, feverishness, headache. First symptoms 4/18/2022 - resolved after 7-10 days
Mild to severe headache  Moderate to severe muscle aches  Fatigue Chills  Feeling Ill (like has the flu)  Loss of appetite  Body weakness  Drippy nose
Localized erythema to left deltoid less than 48 hours after administration. Area 2 inches in length and 1.5 inches in diameter.
3MAY93 h/a, t99.6, face, neck feel hot-not red- nauseated day of shot & pain in inject, extremely tired;
Loss of memory of recent events of morning. Occurred when planting flowers.  Lasted 3-4 hrs. Regained memory little at a time by 6:00 pm same day.   No headache, dizziness, or pain.  No signs of physical distress.  I knew who and where I was. Recognized the people I was with.
FEELING NUMBNESS IN THE ARM, FEELING AS IF ARM IS FALLING ASLEEP, DROPPING THINGS. STARTED 2 DAYS AFTER SHOT. OTHER THAN THAT SORENESS, RED SPOT.
She developed a rash at the injection site yesterday.; This is a spontaneous report from a contactable Nurse via Pfizer sales representative. A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration on unspecified date of Feb2021 as unknown, single for Covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient received vaccine two weeks ago. On 04Feb2021 the patient developed a rash at the injection site yesterday. Patient took Benadryl for the rash. The outcome of the event was unknown.  Information on the lot/ batch number has been requested.
second dose of Jynneos administrated intradermally; The vial was opened yesterday and was administered today.; second dose of Jynneos administered 42 days after the first dose; Case reference number US-BN-2022-004012 is a spontaneous case report initially received on 11-Oct-2022 from a nurse via Agency (reference number: USBAV22-1680) and concerns a 36-year-old male patient.  The patient's medical history and concomitant medications details were not provided.  On 30-Aug-2022, the patient was vaccinated with a first dose of Jynneos vaccine (smallpox and monkeypox vaccine, live, nonreplicating; batch number: unknown) at an unknown dose, administered subcutaneously (SC), at unknown anatomical location, for monkeypox (smallpox) prophylaxis.  On 11-Oct-2022, 42 days after the first dose, the patient was vaccinated with a second dose of Jynneos vaccine (smallpox and monkeypox vaccine, live, nonreplicating; batch number: FPD00005), (explicitly coded as 'inappropriate schedule of vaccine administrated'), at an unknown dose, administered intradermally (ID), (explicitly coded as 'intradermal injection'), at unknown anatomical location, for monkeypox (smallpox) prophylaxis.  The nurse reported that the patient received the second dose that was beyond use date (explicitly coded as 'expired product administered'). As reported, the vial was opened yesterday and was administered today.  At the time of this report, it was unknown if the patient experienced any adverse event.  Additional information received on 11-Oct-2022 from Bavarian Nordic included local BN case ID.  No further information was provided.; Reporter's Comments: A 36-year-old male patient was vaccinated with a second dose of Jynneos vaccine 42 days after the first dose, administered intradermally for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. The nurse reported that the patient received the second dose that was beyond use date. No associated adverse events were reported. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are listed per company convention. The patient's medical history and concomitant medications details were not provided. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are not related to Jynneos, but to a human factor. The case is non-serious.; Sender's Comments: A 36-year-old male patient was vaccinated with a second dose of Jynneos vaccine 42 days after the first dose, administered intradermally for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. The nurse reported that the patient received the second dose that was beyond use date. No associated adverse events were reported. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are listed per company convention. The patient's medical history and concomitant medications details were not provided. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are not related to Jynneos, but to a human factor. The case is non-serious.
Injection site reactions: itching redness hives warm to touch 2.5 inch by 3 inch redness at site
Patient has received 2nd dose of Pfizer, he had received 1st dose of Moderna.  Admin and Vaccinator did not realize until Admin was about to write vaccine info. on vaccination card.
Patient called occupational health complaining of red rash on chest and injection site. Patient was also complaining of itchy scalp.  Patient was told to seek medical assistance by going to an urgent care or a doctor's office.  I called the patient to assess how she was doing later that day. She stated that she started to have wheezes when she first arrived at the ER. She stated that they treated her by giving her steroids, Benadryl and Albuterol to treat her reaction to the vaccine. She stated that she is doing a lot better now and her wheezing and red rash was improving.
Immediate hearing loss/ heavy ringing...I was sitting on my couch watching TV. I want from hearing to non-hearing in an instant. I noticed there is a feeling of pressure in the ear area. I now have a heavy ringing with some random "ticking" in the ear. I am not able to hear anything short of really loud noises that sound like metallic screeching.
Symptoms lasted from 5-7 days depending upon the symptom. Pain, swelling, itching, redness extending from upper arm travelling down to elbow, hotness, headache, muscle pain, fatigue, fever, chills & shivering, disorientation, tightness in chest overnight. We took picture of arm redness. I did not have any energy or even felt good for over 1 week. I went by  & showed my arm to a Pharmacist. I also went by & showed my arm to a doctor. I need to know whether I should have the second shot in this series. I got on the website & saw that if you do not get the second shot, it will not be effective. I had  a really bad case of shingles  about 10-12 years ago.
whole body ache; I had low grade fever (38.2 C) for one day; I also had injection site sore; fatigue; This is a spontaneous report from a contactable other hcp (patient). A 53-years-old non pregnant female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 24Mar2021 (Lot Number: EP6955) as single dose for covid-19 immunisation. The patient's medical history was not reported. Concomitant medications in two weeks included paracetamol(TYLENOL). Patient had a historical vaccine of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 (Lot Number: EL3247) as single dose for covid-19 immunisation. On 25Mar2021, the patient reported i had low grade fever (38.2 c) for one day, i also had injection site sore, whole body ache and fatigue for 3 days. No reaction after receiving the 1st dose. The patient underwent lab tests and procedures which included body temperature: 38.2 centigrade on 25Mar2021. Therapeutic measures were taken as a result of all the events. Outcome of the event fever was recovered on 26Mar2021 and events injection site sore, whole body ache and fatigue were recovered on 28Mar2021.  No follow-up attempts are possible. No further information is expected.
My son developed a red rash behind his knees. The rash persisted, and we treated it with a hydrocortisone cream. He was diagnosed with dermatitis on Jan. 26th, 2015.  His eczema continued, and he also developed a few small bumps (like pimples).  My husband (an MD) told me that it was just part of the eczema and that it would pass on its own.  We were so busy with moving into a rental home while building a new home and moving in, I didn't take my son back to address the tiny bumps for a long time (as they didn't seem to bother him).  We were told it was molluscum, and that it may take a year to clear up. At that point, he'd had the virus for so long, it cleared up within a few months of that visit.
Initial report received from a health care professional on 17 January 2012. A male neonate received transplacental MENACTRA, sanofi pasteur Inc. lot number U3678A, and transplacental Tdap, manufacturer unknown, lot number C3928AA, which is not a valid sanofi Pasteur lot number, on 18 January 2011. The patient's mother had a maternal aunt with tricuspid atresia and transposition of the great vessels. It was noted that the mother prenatal laboratory testing was as follows: prenatal (PN) profile on 15 February 2011 within normal limits (WNL), negative sexually transmitted diseases (STD) on 23 February 2011, PN 28 week labs on 11 July 2011 were WNL and chorionic villus sampling (CVS) on 04 March 2011 for PN diagnosis. The mothers ultrasound findings were as follows: 02 March 2011 showed thickened nuchal fold and edema; on 04 March 2011, 05 April 2011, 03 May 2011, 25 May 2011 and 13 July 2011 showed cystic hygroma and multiple fetal anomalies. On 08 August 2011, the patient's mother developed premature rupture of membranes (PROM) and had a Cesarean section on 09 August 2011 and subsequent neonatal death. The neonate was delivered at 34 weeks of gestation by a Cesarean section with a weight of 1.915 kilograms (Kg) and an Apgar score of one at one minute and an APGAR score of one at five minutes. The neonate was born with multiple fetal anomalies not compatible with life, myotonic dystrophy or arthrogryposis, dilated bowel, possible bowel obstruction and cystic hygroma. The neonate death was caused by multiple congenital anomalies. The outcome was fatal on 09 August 2011. The mother case is captured in case number 2011-00541. Documents held by sender: Pregnancy form.
Red, warm flat rash left upper arm. with flushing and slight raised are of rash to chest and neck. Seen and observed in ED, TX with Anti histamine.
pt recvd Engerix-B & exp severe burning of the bottom of feet; on occasion can hardly walk; pt attributed it to just getting old;
was pretty sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (was pretty sick) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Encephalitis (immunocompromised with chronic encephalitis).    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced ILLNESS (was pretty sick). At the time of the report, ILLNESS (was pretty sick) had resolved.            Patient took Johnson and Johnson for the first 2 shots and then have a Moderna shot because he is immunocompromised with chronic encephalitis.  The concomitant medications were not reported.  Th treatment information was not provided.
Left upper arm posterior area reddened, warm, not indurated, size approximately of a small grapefruit. No antibiotics ordered, treated with ice pack.
RA red, swollen, feverish. Localized Rt upper arm deltoid-cellulitis/local allergic rxn treated with 6 days of Zyrtec, warm soaks and mobic-resolved.
Pt. states that after receiving the 1st dose of Flu Shot (High Dose)/2nd dose of Pneumonia 23 09/28/2021. started experiencing symptoms that evening of Vomiting, nausea, uncontrollable shaking, weakness, chills, and headache. Headache and shaking still continue. No noted Primary visit.
One day post vax the pt developed 3 liquid filled blisters approximately the size of pencil erasers. The next week the pt developed acute bronchitis with flu-like symptoms. Was seen by physician.
mom states started w/diarrhea & vomiting about 1030PM & last all day;pedialyte did not help then eyes started rolling back in head;taken to ER;T101;
pt recv vax 3APR(7 & 14APR97 & devel over 100 lesions;Eval by PCR revealed a specimen was VZV positive, however it was not typeable;
Pt was given 2 ANTHRAX shots within 5 minutes of each other each 0.5cc. No signs of Adverse reactions. Consulted with infectious disease LT.
sx of gulf war syndrome; asthma; increased migraine h/a; resp recurring infect; fibromyalgia; loss of memory long & short term; fatigue; blurred vision; dizziness; nausea
My arm began to get sore the same  day of vaccination around 8pm I noticed it was very, very sore and I started putting cold compress and took Tylenol it lasted till Wednesday and my bed time on Wednesday the 7th and my chest all the way to my collarbone it was very swollen and felt squishy and when I woke up Thursday 7/8 morning I felt big lump across my collar bone going down to my left shoulder.  My doctor said it should resolve within a couple of days on its own and it did.
Approximately 19 hours after having the vaccination, I awoke with a sore arm, stiff neck, and pinpoint headache.  These symptoms continued throughout the day.  At approximately 1:30 pm, I took 2x500mg acetaminophen and the stiff neck and headache pretty much went away.